Dr. Crystal Broussard, MD
Board Certified in Family Medicine · Advanced Training in Obesity Medicine
Updated March 19, 2026
Quick Insights
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell that plays a critical role in energy production, DNA repair, and cellular aging processes. IV infusion delivers NAD+ directly into the bloodstream, bypassing digestive breakdown and producing measurable changes in NAD+ metabolites within hours. While research suggests promising metabolic effects, clinical evidence for long-term anti-aging outcomes remains in early stages, and the FDA has issued safety warnings about compounding quality for IV formulations. Results vary by individual, and NAD+ IV therapy is not yet established as a standard treatment for wellness or anti-aging indications.
Key Takeaways
-
NAD+ supports mitochondrial energy production, DNA repair enzymes, and sirtuin proteins involved in cellular aging processes -
A pilot study found that direct IV infusion produces time-dependent increases in NAD+ metabolites in plasma and urine within 2–6 hours of administration -
Emerging research suggests NAD+ therapies may influence aging-related biomarkers, though clinical evidence is heterogeneous and long-term outcomes require further study -
The FDA has warned about contamination risks with food-grade NAD+ ingredients used in compounded IV formulations, emphasizing the importance of pharmaceutical-grade sourcing and sterile compounding practices
Why It Matters
Active adults balancing demanding careers, family responsibilities, and fitness goals often notice subtle shifts in energy, recovery, and mental clarity as they age, changes that can feel frustrating when conventional approaches offer limited solutions. NAD+ IV therapy represents an emerging area of cellular wellness that addresses energy production at the mitochondrial level, appealing to health-conscious individuals seeking science-informed approaches to support vitality and healthy aging. For patients pursuing proactive wellness strategies, understanding both the potential and the limitations of NAD+ therapy helps inform meaningful conversations with a physician about whether this treatment aligns with their health goals.
What Is NAD+ IV Therapy and Why Are Patients Asking About It?
“Can an IV infusion actually support cellular aging?” It is one of the most thoughtful questions I hear from patients who are researching proactive wellness strategies beyond conventional supplements. NAD IV therapy has generated significant interest among adults exploring the science of cellular energy, and for good reason: nicotinamide adenine dinucleotide is a naturally occurring coenzyme essential for energy metabolism, DNA repair, and cellular health that declines as we age.
Intravenous delivery offers a method of providing NAD+ directly to the bloodstream, bypassing the digestive limitations that can reduce oral supplement absorption. A pilot study published in Frontiers in Aging Neuroscience demonstrated that a 6-hour IV NAD+ infusion produced measurable, time-dependent changes in the NAD+ metabolome in plasma and urine, confirming that IV delivery is metabolically active in humans (Frontiers in Aging Neuroscience 2019).
In this article, I will walk through how NAD+ functions at the cellular level, what current research shows and does not show, important safety considerations including FDA warnings about compounding quality, and how I approach conversations with patients about emerging therapies. As a physician with approximately 20 years of clinical experience evaluating wellness treatments, I believe patients deserve honest, evidence-informed guidance about both the promise and the limitations of therapies like NAD+ IV.
Important Safety Information
NAD+ IV therapy is not FDA-approved for anti-aging, energy, or wellness indications and remains under investigation. The FDA has issued warnings about compounded NAD+ IV products made with food-grade ingredients (rather than pharmaceutical-grade), citing risks of microbial contamination and endotoxin exposure. The agency has received adverse event reports including severe chills, shaking, vomiting, and fatigue consistent with endotoxin contamination (FDA 2024).
Patients considering NAD+ IV should seek treatment only from physician-supervised practices using pharmaceutical-grade, sterile-compounded formulations. Individuals with cardiovascular conditions, kidney disease, active infections, or those who are pregnant or breastfeeding should consult their physician before pursuing NAD+ therapy. Adverse reactions should be reported to the FDA via MedWatch.
How NAD+ Functions in Cellular Energy and Aging
NAD+ is a coenzyme found in every living cell, essential for converting the nutrients you consume into ATP (the molecule your mitochondria produce to power cellular functions). Beyond its role in energy metabolism, NAD+ participates in redox reactions that transfer electrons during metabolic processes, and it serves as a critical substrate for enzymes involved in DNA repair (called PARPs) and cellular stress response (called sirtuins).
What makes NAD+ particularly relevant to aging is that levels decline over time. Research indicates that this decline occurs through both increased consumption by repair enzymes responding to accumulated cellular damage and decreased synthesis, a combination that may contribute to age-related mitochondrial dysfunction and metabolic decline (Endocrine Reviews 2023). A foundational review in Trends in Cell Biology described NAD+ decline during aging as a potential “Achilles’ heel, causing defects in nuclear and mitochondrial functions” (Trends in Cell Biology 2014).
A 2026 systematic review analyzing 113 studies (including 33 human trials) found that NAD+ precursors and NAD+-related therapies can elevate NAD+ levels and influence aging-related biomarkers. However, the review concluded that “effects on functional, metabolic, vascular, and other healthspan-relevant outcomes were heterogeneous and often null,” and that “clinical effectiveness for anti-aging or wellness outcomes remains inconclusive” (Ageing Research Reviews 2026). This honest assessment reflects where the science currently stands: the mechanistic rationale is compelling, but clinical translation requires further study.
Three Key Cellular Pathways NAD+ Supports
Mitochondrial Energy
NAD+ drives ATP production in the electron transport chain
DNA Repair
NAD+ fuels PARP enzymes that fix DNA strand breaks
Sirtuin Activation
NAD+ powers “longevity proteins” that regulate cellular stress
Mitochondrial Energy Production
NAD+ is required for the electron transport chain in your mitochondria, where it accepts and donates electrons to generate ATP (the energy currency your cells depend on for every function from muscle contraction to cognitive processing). When NAD+ levels decline, mitochondrial efficiency may diminish, potentially contributing to the fatigue and reduced cellular resilience that many adults notice as they age.
Research has documented that NAD+ supplementation can elevate NAD+ levels in both preclinical models and some human studies, with measurable effects on metabolic markers. However, translation to clinical energy outcomes varies considerably by study design, dosing protocol, and population studied (Ageing Research Reviews 2026). The mechanistic rationale is strong, but individual responses remain variable.
DNA Repair and Genomic Stability
NAD+ serves as a substrate for PARP enzymes (the molecular repair crew responsible for fixing DNA strand breaks caused by oxidative stress, environmental toxins, and normal metabolic processes). When DNA damage accumulates over time, PARP enzymes work harder and consume more NAD+, creating a cycle where increased repair demands deplete the very molecule needed to fuel those repairs.
This cycle may accelerate aspects of cellular aging. Restoring NAD+ availability could support DNA repair capacity by ensuring PARPs have adequate substrate to function. However, direct evidence of improved genomic stability outcomes in humans specifically from IV NAD+ therapy remains limited, and further research is needed to establish clinical benefits beyond the mechanistic rationale.
Sirtuin Activation and Cellular Longevity
Sirtuins are a family of NAD+-dependent enzymes that regulate gene expression, inflammation, and stress resistance. Often described as “longevity proteins” due to their role in caloric restriction pathways and lifespan extension in animal models, sirtuins depend on NAD+ availability to function. Increasing NAD+ levels may enhance sirtuin-mediated cellular maintenance processes, including mitochondrial biogenesis and inflammatory regulation.
It is important to note that while preclinical data on sirtuins is compelling, more recent work has challenged some earlier assumptions about sirtuins as conserved regulators of longevity. A comprehensive review in Endocrine Reviews noted that the clinical pharmacology and therapeutic mechanisms of NAD+ precursors “remain incompletely understood,” and that human evidence for sirtuin-related anti-aging outcomes from NAD+ therapy is early-stage with variable results (Endocrine Reviews 2023).
What the Research Shows About NAD+ IV Infusion in Spring, TX
The most direct evidence for IV NAD+ delivery comes from a 2019 pilot study that administered NAD+ intravenously at 3 µmol/min over 6 hours. Researchers found that no changes in plasma NAD+ or metabolites appeared until after the 2-hour mark, with increased urinary excretion of NAD+ and methylnicotinamide detected by hour six. The study confirmed that IV-delivered NAD+ is metabolized systemically and produces measurable pharmacokinetic changes, but it did not assess long-term clinical outcomes such as energy levels, cognitive function, or aging biomarkers (Frontiers in Aging Neuroscience 2019).
Clinical Research Note
Grant et al. (Frontiers in Aging Neuroscience 2019, n=8 test/n=3 control): 6-hour IV NAD+ infusion produced time-dependent increases in urinary NAD+ and methylnicotinamide; no plasma metabolite changes until after 2 hours. No long-term clinical outcomes measured.
When we consider the broader landscape of NAD+ research through vitamin IV infusion therapies, the evidence base shows that NAD+ precursors and related therapies can influence aging-related biomarkers in various study designs. However, the most comprehensive systematic review to date (analyzing 113 studies across human and animal models) concluded that clinical evidence remains heterogeneous with varying safety profiles and dosing considerations, and that rigorous long-term trials with clinically meaningful endpoints are still needed. This means NAD+ IV is metabolically active, but its value for specific wellness and anti-aging outcomes has not been conclusively established.
NAD+ Therapy and Proactive Wellness in the North Houston Area
Whether you are an active professional balancing weekend trail runs along Spring Creek Greenway or managing a demanding schedule while raising a family, subtle shifts in energy, recovery, and mental clarity can feel frustrating when conventional approaches offer limited solutions. For patients throughout Spring, The Woodlands, Tomball, and Kingwood, NAD+ IV therapy reflects a growing interest in mitochondrial and metabolic wellness, an approach that seeks to address the cellular roots of age-related decline rather than managing symptoms alone.
While NAD+ therapy is still being studied for wellness applications, the scientific conversation around cellular energy, DNA repair, and sirtuin biology is advancing rapidly. Physician-supervised practices like Harmony Aesthetics Spa provide the medical oversight, pharmaceutical-grade sourcing, and individualized assessment necessary to explore emerging therapies safely. As a physician-owned practice, we approach these treatments with the same clinical rigor we apply to our established services at our Spring location, evaluating each patient’s health history, goals, and the current state of the evidence before recommending any course of treatment.
When Is It Time to Talk to Dr. Crystal About NAD+ IV Therapy?
Not every patient is a candidate for NAD+ IV therapy, and that is exactly why a physician conversation matters. Consider scheduling a consultation if any of these resonate with your experience:
Consider a Consultation If…
You are experiencing persistent fatigue, brain fog, or reduced exercise recovery that has not improved with sleep, nutrition, or stress management strategies
You are interested in proactive, cellular-level approaches to healthy aging and want to understand both the potential and the limitations of emerging therapies
You have read about NAD+ online or heard about it from wellness communities and want a physician’s perspective on safety, sourcing, and appropriateness for your health history
You are already pursuing other metabolic or wellness treatments (such as hormone optimization or weight management) and want to explore complementary strategies under medical supervision
“These are exactly the kinds of questions I want patients to bring to me, so we can evaluate whether an emerging therapy like NAD+ IV makes sense for your goals, your health history, and the current state of the evidence.”
What to Expect During an NAD+ IV Consultation at Harmony Aesthetics Spa
Health Review
Medical history, symptoms, wellness goals, contraindications
Evidence Discussion
Current research, realistic expectations, candidacy assessment
Infusion Session
Slow IV administration, several hours, pharmaceutical-grade NAD+
Follow-Up Plan
Individualized protocol based on your response and goals
Your consultation begins with me or my clinical team reviewing your health history, current symptoms, wellness goals, and any contraindications including cardiovascular conditions, kidney disease, active infections, or pregnancy. I believe patients should understand both the potential benefits and the current evidence limitations of NAD+ therapy before making any treatment decisions.
The infusion itself involves slow IV administration over several hours. In my practice, sessions typically take 2–6 hours based on dosing and individual tolerance, in a comfortable, monitored setting. Our practice uses only pharmaceutical-grade, sterile-compounded NAD+ formulations, a distinction that matters given the FDA’s documented warnings about food-grade ingredients causing adverse reactions in compounded IV products (FDA 2024). Patients are monitored throughout the infusion for any adverse reactions, and treatment plans are individualized based on each patient’s response and goals.
Comparing NAD+ IV Therapy and Oral NAD+ Precursor Supplements
| Feature | Physician-Supervised NAD+ IV Therapy | Oral NAD+ Precursor Supplements |
|---|---|---|
| Delivery Method | Direct intravenous infusion | Oral capsule or powder |
| Bioavailability | Bypasses digestive breakdown; a pilot study documented measurable plasma metabolite changes within hours | Subject to digestive metabolism and first-pass effects; absorption may vary by individual |
| Medical Oversight | Administered under physician supervision with health history review and continuous monitoring | Self-administered; typically no medical assessment or monitoring |
| Sourcing and Safety | Pharmaceutical-grade, sterile-compounded formulation per FDA guidance | Over-the-counter; quality and purity may vary by manufacturer |
| Evidence Base | Pilot studies show metabolomic changes; long-term clinical outcomes still being studied | Precursor studies (NR, NMN) show NAD+ elevation; clinical outcomes are heterogeneous |
| Individualization | Dosing and protocol tailored to patient health status, tolerance, and goals | Standardized dosing; limited personalization |
Both approaches have evidence supporting NAD+ elevation, though through different mechanisms. The choice between IV and oral delivery depends on individual health goals, medical history, and physician guidance. Results vary by individual.
Taking the Next Step Toward Cellular Wellness
NAD+ IV therapy represents an emerging approach to cellular energy and aging, grounded in real science about mitochondrial function, DNA repair, and sirtuin pathways, but still under investigation for wellness and anti-aging outcomes. The pilot research confirms that NAD+ can be delivered systemically and metabolized, and broader evidence suggests potential for influencing aging biomarkers, though clinical outcomes are variable and long-term studies are needed. Outcomes depend on individual factors, and I discuss realistic expectations with every patient.
Safety depends on pharmaceutical-grade sourcing and physician oversight, especially given the FDA’s documented concerns about compounding quality. If you are curious about whether NAD+ IV therapy aligns with your health goals, schedule a consultation with me at Harmony Aesthetics Spa to discuss the current evidence, assess your candidacy, and explore a physician-supervised approach to proactive wellness. You can also call or text us at (346) 597-1202 and we welcome your questions.
Harmony Aesthetics Spa · Spring, TX
Schedule Your NAD+ IV Consultation
Discuss the current evidence, assess your candidacy, and explore a physician-supervised approach. Call or text (346) 597-1202, or book online.
We serve patients throughout Spring and the greater North Houston area.
Medical Disclaimer
This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. NAD+ IV therapy is not FDA-approved for anti-aging, energy, or wellness indications and is considered investigational. Results vary based on individual factors including health status, baseline levels, and treatment goals. Always consult with a qualified physician before starting any new treatment.
Dr. Crystal Broussard, MD
Board Certified in Family Medicine · Fellow of the American Board of Obesity Medicine · Founder & Medical Director, Harmony Aesthetics Spa
Dr. Broussard specializes in physician-supervised wellness, medical weight loss, and integrative aesthetics, bringing clinical precision and personal experience to every patient’s care plan.